Similar articles

• [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].

  Dryzhak VI. Dryzhak VI. Vopr Onkol. 1989;35(7):771-8. Vopr Onkol. 1989. PMID: 2528239 Review. Russian. No abstract available.
• [Value of hormone therapy in metastasizing breast cancer].

  Samonigg H. Samonigg H. Wien Med Wochenschr. 1985 Dec 31;135(23-24):602-7. Wien Med Wochenschr. 1985. PMID: 2937208 German.
• Tamoxifen therapy of metastatic breast cancer.

  Manni A. Manni A. J Lab Clin Med. 1987 Mar;109(3):290-9. J Lab Clin Med. 1987. PMID: 2950193 Review.
• [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].

  Blossey HC, Wander HE, Nagel GA, Köbberling J, Kleeberg U. Blossey HC, et al. Onkologie. 1982 Aug;5 Suppl:34-41. Onkologie. 1982. PMID: 6290955 German.
• [Adjuvant hormone therapy of primary breast cancer. Review of the literature].

  Focan C. Focan C. Rev Med Liege. 1991 May;46(5):270-8. Rev Med Liege. 1991. PMID: 1830160 Review. French. No abstract available.